These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Sainz de la Maza M; Adán A Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema. Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610 [TBL] [Abstract][Full Text] [Related]
4. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients. Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771 [TBL] [Abstract][Full Text] [Related]
5. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients. Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report. Adán A; Moll-Udina A; Ramirez J; Llorenç V Ocul Immunol Inflamm; 2021 Jan; 29(1):6-8. PubMed ID: 31589540 [No Abstract] [Full Text] [Related]
7. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment. Deuter CME; Zierhut M; Igney-Oertel A; Xenitidis T; Feidt A; Sobolewska B; Stuebiger N; Doycheva D Ocul Immunol Inflamm; 2017 Apr; 25(2):215-220. PubMed ID: 26731514 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
10. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients. Barroso-García N; Atienza-Mateo B; Ferraz-Amaro I; Prieto-Peña D; Beltrán E; Adán A; Hernández-Garfella M; Martínez-Costa L; Cordero-Coma M; Díaz-Llopis M; Herreras JM; Maíz-Alonso O; Torre-Salaberri I; De Vicente-Delmás A; Díaz-Valle D; Atanes-Sandoval A; Francisco F; Insua S; Sánchez J; Almodóvar-González R; Jiménez-Sosa A; Ruiz-Moreno O; Gandía-Martínez M; Nolla JM; Calvo-Río V; Castañeda S; González-Gay MA; Blanco R Semin Arthritis Rheum; 2023 Feb; 58():152153. PubMed ID: 36549244 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review. Calvo-Río V; Blanco R; Santos-Gómez M; Díaz-Valle D; Pato E; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA Ocul Immunol Inflamm; 2017 Oct; 25(5):604-609. PubMed ID: 27726475 [TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047 [TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis. Schaap-Fogler M; Amer R; Friling R; Priel E; Kramer M Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):633-40. PubMed ID: 24366669 [TBL] [Abstract][Full Text] [Related]
14. Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema - A case report. Babu K; Sudheer B; Rao AP Indian J Ophthalmol; 2019 Jun; 67(6):975-977. PubMed ID: 31124539 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L; Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901 [TBL] [Abstract][Full Text] [Related]
16. Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis. Sepah YJ; Sadiq MA; Chu DS; Dacey M; Gallemore R; Dayani P; Hanout M; Hassan M; Afridi R; Agarwal A; Halim MS; Do DV; Nguyen QD Am J Ophthalmol; 2017 Nov; 183():71-80. PubMed ID: 28887113 [TBL] [Abstract][Full Text] [Related]
17. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis]. Breitbach M; Rack D; Dietzel M; Heinz C; Heiligenhaus A Klin Monbl Augenheilkd; 2016 May; 233(5):601-5. PubMed ID: 27187880 [TBL] [Abstract][Full Text] [Related]